110 related articles for article (PubMed ID: 7968791)
21. A new procoagulant in acute leukemia.
Falanga A; Alessio MG; Donati MB; Barbui T
Blood; 1988 Apr; 71(4):870-5. PubMed ID: 3355894
[TBL] [Abstract][Full Text] [Related]
22. Discrepancy between tissue factor activity and tissue factor expression in endotoxin-induced monocytes is associated with apoptosis and necrosis.
Henriksson CE; Klingenberg O; Ovstebø R; Joø GB; Westvik AB; Kierulf P
Thromb Haemost; 2005 Dec; 94(6):1236-44. PubMed ID: 16411400
[TBL] [Abstract][Full Text] [Related]
23. Effect of ATRA and ATO on the expression of tissue factor in NB4 acute promyelocytic leukemia cells and regulatory function of the inflammatory cytokines TNF and IL-1β.
Dunoyer-Geindre S; Rivier-Cordey AS; Tsopra O; Lecompte T; Kruithof EKO
Ann Hematol; 2017 Jun; 96(6):905-917. PubMed ID: 28343272
[TBL] [Abstract][Full Text] [Related]
24. Cancer procoagulant in the human promyelocytic cell line NB4 and its modulation by all-trans-retinoic acid.
Falanga A; Consonni R; Marchetti M; Mielicki WP; Rambaldi A; Lanotte M; Gordon SG; Barbui T
Leukemia; 1994 Jan; 8(1):156-9. PubMed ID: 8289480
[TBL] [Abstract][Full Text] [Related]
25. Phenotypic and ultrastructural characterization of a medullary thymocyte acute lymphoblastic leukemia with cellular procoagulant activity.
Chorba TL; Orenstein JM; Ney AB; Schwartz BS; Alabaster O; Kessler CM; Cohen P; Schulof RS
Cancer; 1985 Feb; 55(3):675-81. PubMed ID: 3880664
[TBL] [Abstract][Full Text] [Related]
26. Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation.
Langer F; Spath B; Haubold K; Holstein K; Marx G; Wierecky J; Brümmendorf TH; Dierlamm J; Bokemeyer C; Eifrig B
Ann Hematol; 2008 Jun; 87(6):451-7. PubMed ID: 18292996
[TBL] [Abstract][Full Text] [Related]
27. Increased human tumor necrosis factor-α levels induce procoagulant change in porcine endothelial cells in vitro.
Lee KG; Lee H; Ha JM; Lee YK; Kang HJ; Park CG; Kim SJ
Xenotransplantation; 2012; 19(3):186-95. PubMed ID: 22702470
[TBL] [Abstract][Full Text] [Related]
28. Tissue factor gene expression in acute myeloblastic leukemia.
Bauer KA; Conway EM; Bach R; Konigsberg WH; Griffin JD; Demetri G
Thromb Res; 1989 Nov; 56(3):425-30. PubMed ID: 2617479
[TBL] [Abstract][Full Text] [Related]
29. Tissue factor messenger RNA levels in leukocytes compared with tissue factor antigens in plasma from patients in hypercoagulable state caused by various diseases.
Sase T; Wada H; Kamikura Y; Kaneko T; Abe Y; Nishioka J; Nobori T; Shiku H
Thromb Haemost; 2004 Jul; 92(1):132-9. PubMed ID: 15213854
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis of cancer-associated vascular disorders.
Naschitz JE; Yeshurun D; Eldar S; Lev LM
Cancer; 1996 May; 77(9):1759-67. PubMed ID: 8646671
[TBL] [Abstract][Full Text] [Related]
31. Saphenous vein thrombophlebitis (SVT): a deceptively benign disease.
Hanson JN; Ascher E; DePippo P; Lorensen E; Scheinman M; Yorkovich W; Hingorani A
J Vasc Surg; 1998 Apr; 27(4):677-80. PubMed ID: 9576081
[TBL] [Abstract][Full Text] [Related]
32. [Effects of arsenic trioxide or retinoic acid on mRNA and protein expression of tissue factor and thrombomodulin and procoagulant activity in NB4 cells].
Zhang XH; Hu Y; Hong M; Xia LH; Guo T; Shen GX; Wei WN; Song SJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):391-5. PubMed ID: 17493354
[TBL] [Abstract][Full Text] [Related]
33. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.
Dombret H; Scrobohaci ML; Ghorra P; Zini JM; Daniel MT; Castaigne S; Degos L
Leukemia; 1993 Jan; 7(1):2-9. PubMed ID: 8418375
[TBL] [Abstract][Full Text] [Related]
34. Microparticle-associated tissue factor activity in patients with acute unprovoked deep vein thrombosis and during the course of one year.
Thaler J; Koppensteiner R; Pabinger I; Ay C; Gremmel T
Thromb Res; 2014 Nov; 134(5):1093-6. PubMed ID: 25262106
[TBL] [Abstract][Full Text] [Related]
35. Mechanistic insight into the procoagulant activity of tumor-derived apoptotic vesicles.
Muhsin-Sharafaldine MR; Kennedy BR; Saunderson SC; Buchanan CR; Dunn AC; Faed JM; McLellan AD
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):286-295. PubMed ID: 27864149
[TBL] [Abstract][Full Text] [Related]
36. In vitro generation of procoagulant activity by leukemic promyelocytes in response to cytotoxic drugs.
Fibach E; Treves A; Korenberg A; Rachmilewitz EA
Am J Hematol; 1985 Nov; 20(3):257-65. PubMed ID: 3904416
[TBL] [Abstract][Full Text] [Related]
37. Hypercoagulability and tissue factor gene upregulation in hematologic malignancies.
Falanga A; Barbui T; Rickles FR
Semin Thromb Hemost; 2008 Mar; 34(2):204-10. PubMed ID: 18645927
[TBL] [Abstract][Full Text] [Related]
38. Potential role of interleukin-1 as the trigger for diffuse intravascular coagulation in acute nonlymphoblastic leukemia.
Cozzolino F; Torcia M; Miliani A; Carossino AM; Giordani R; Cinotti S; Filimberti E; Saccardi R; Bernabei P; Guidi G
Am J Med; 1988 Feb; 84(2):240-50. PubMed ID: 3261536
[TBL] [Abstract][Full Text] [Related]
39. Cancer procoagulant in human tumor cells: evidence from melanoma patients.
Donati MB; Gambacorti-Passerini C; Casali B; Falanga A; Vannotti P; Fossati G; Semeraro N; Gordon SG
Cancer Res; 1986 Dec; 46(12 Pt 1):6471-4. PubMed ID: 3536081
[TBL] [Abstract][Full Text] [Related]
40. [Role of Microparticles Derived from Acute Promyelocytic Leukemia Cells in Coagulopathy].
Zhang YM; Chen B; Wu LY; Hou JX; Fu JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):693-698. PubMed ID: 28641620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
